Bayer HealthCare Pharmaceuticals and Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX) today announced results from two collaborative group-sponsored randomized, double-blind, placebo-controlled Phase ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE